Atea Pharmaceuticals Inc (NASDAQ: AVIR) kicked off on Friday, up 1.20% from the previous trading day, before settling in for the closing price of $3.33. Over the past 52 weeks, AVIR has traded in a range of $2.75-$4.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 130.62% over the last five years. While this was happening, its average annual earnings per share was recorded -10.74%. With a float of $74.01 million, this company’s outstanding shares have now reached $84.46 million.
The firm has a total of 75 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Atea Pharmaceuticals Inc (AVIR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Atea Pharmaceuticals Inc is 12.38%, while institutional ownership is 66.05%. The most recent insider transaction that took place on Dec 10 ’24, was worth 1,023,475. In this transaction Director of this company sold 359,606 shares at a rate of $2.85, taking the stock ownership to the 451,897 shares. Before that another transaction happened on Dec 10 ’24, when Company’s Lead Independent Director proposed sale 359,606 for $2.85, making the entire transaction worth $1,023,475.
Atea Pharmaceuticals Inc (AVIR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -10.74% per share during the next fiscal year.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Trading Performance Indicators
Take a look at Atea Pharmaceuticals Inc’s (AVIR) current performance indicators. Last quarter, stock had a quick ratio of 19.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.07, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.58 in one year’s time.
Technical Analysis of Atea Pharmaceuticals Inc (AVIR)
Analysing the last 5-days average volume posted by the [Atea Pharmaceuticals Inc, AVIR], we can find that recorded value of 0.52 million was better than the volume posted last year of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 50.45%. Additionally, its Average True Range was 0.15.
During the past 100 days, Atea Pharmaceuticals Inc’s (AVIR) raw stochastic average was set at 44.44%, which indicates a significant decrease from 53.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.12% in the past 14 days, which was lower than the 44.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.26, while its 200-day Moving Average is $3.54. Now, the first resistance to watch is $3.45. This is followed by the second major resistance level at $3.53. The third major resistance level sits at $3.57. If the price goes on to break the first support level at $3.32, it is likely to go to the next support level at $3.28. Should the price break the second support level, the third support level stands at $3.20.
Atea Pharmaceuticals Inc (NASDAQ: AVIR) Key Stats
The company with the Market Capitalisation of 284.64 million has total of 84,463K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -135,960 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -31,150 K.
